Tobin Schilke, Chief Financial Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 6,713 shares at $39.67 ($266K) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Scheduled sale ($266k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVNC | SELL | 2023-06-05 | $181K | — | Filing → |
| RVNC | SELL | 2023-05-16 | $1.5M | — | Filing → |
| RVNC | SELL | 2023-05-02 | $203K | — | Filing → |